Screener
Lexicon Pharmaceuticals LXRX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Accounts payable | $2,343 | $3,083 |
| Accrued liabilities | 12,363 | 13,189 |
| Current portion of long-term debt | — | 4,595 |
| Total current liabilities | 14,706 | 20,867 |
| Long-term debt, net | 51,437 | 49,408 |
| Other long-term liabilities | 9,392 | 7,174 |
| Total liabilities | 75,535 | 77,449 |
| Commitments and contingencies (Note 7) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's total current liabilities?
- Lexicon Pharmaceuticals (LXRX) reported total current liabilities of $14.71M in Q2 2026.
- How has Lexicon Pharmaceuticals's total current liabilities changed year-over-year?
- Lexicon Pharmaceuticals's total current liabilities decreased by 57.8% year-over-year, from $34.84M to $14.71M.
- What is the long-term trend for Lexicon Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's total current liabilities has grown at a -14.9% compound annual growth rate (CAGR), from $46.81M to $20.87M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Lexicon Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude